1 Dr. Israt Rezwana, Registrar, Department of Endocrinology, Sir Salimullah Medical College & Hospital, Dhaka.
2 Prof. Dr. Md. Faruque Pathan, Director of BIRDEM Academy, Department of Endocrinology, Dhaka.
3 Prof. Dr. Feroz Amin, Head of the Dept. Department of Endocrinology BIRDEM General Hospital, Dhaka.
4Dr. Md. Arifur Rahman, Registrar, Department of Gastroenterology, Dhaka Medical College Hospital,Dhaka
5 Dr. Md. Mehdi Hasan, Assistant Registrar, Department of Cardiology, National Institute of Cardiovascular Diseases & Hospital, Dhaka.
6 Dr. Nikhil Chandra Roy, Assistant Professor, Department of Gastroenterology, Bangladesh Medical College & Hospital, Dhaka.
7 Dr. Mita Dutta, Medical Officer, Dept. of Endrocrinology, Bangabandhu Sheikh Mujib Medical University, Shahbagh, Dhaka.
8 Dr. Goutom Chandra Bhowmik Assistant Registrar, Department of Cardiology, National Institute of Cardiovascular Diseases & Hospital, Dhaka.
9 Dr. Haripada Roy, Junior Consultant, Department of Cardiology, Kotalipara Upzilla Health Complex, Kotalipara, Gopalgonj, Bangladesh.
10 Dr Sushanta Barua, Assistant Registrar, Department of Cardiology, National Institute of Cardiovascular Diseases & Hospital, Dhaka.
World Journal of Biology Pharmacy and Health Sciences, 2025, 22(01), 356-371
Article DOI: 10.30574/wjbphs.2025.22.1.0336
Received on 16 February 2025; revised on 24 March 2025; accepted on 27 March 2025
Background: Hypothyroidism in patients with cardiac diseases is associated with worse outcomes. However, this has not yet been adequately investigated in Bangladeshi people.
Objective: To find out the Risk Factors of Ischemic Heart Disease Patients Among Hypothyroid Patients
Materials and methods: This cross-sectional observational study, conducted at the Department of Endocrinology and Allied Medicine, BIRDEM General Hospital, recruited 90 consecutive patients with ischemic heart disease but no prior history of hypothyroidism. Serum levels of TSH, FT4, and anti-thyroid peroxidase (TPO) antibodies were measured using an automated analyzer with a chemiluminescent immunoassay method. Subclinical hypothyroidism (SCH) was defined as a TSH level between 4.12 mIU/L and 10 mIU/L, while overt hypothyroidism was defined as a TSH level above 10 mIU/L. We used chi-square tests, the independent sample t-test, One-way ANOVA, The significance level was set at p < 0.05.
Results: Of the 90 enrolled participants, 68 (75.6%) were euthyroid, 15 (16.7%) had subclinical hypothyroidism (SCH), and 7 (7.8%) had overt hypothyroidism. Of the patients with hypothyroidism, 7(31.8%) were anti-TPO antibody positive. Hypothyroidism was significantly more prevalent in females, non-smokers, obese individuals, those with HbA1c ≥ 10%, and patients with LVEF < 50%. In the hypothyroid group, mean ± SD systolic blood pressure, diastolic blood pressure, BMI, and HbA1c were also significantly higher. Although 95.5% of hypothyroid patients had dyslipidemia, there were no significant differences observed in specific lipid profiles between hypothyroid and euthyroid patients. Heart failure patients showed significantly more hypothyroidism and lower mean ± SD FT4 compared to patients without heart failure. Interestingly, mean ± SD TSH was significantly lower in females and the hypothyroid group. Predictors for hypothyroidism in IHD patients were female gender, non-smoker, higher BMI, higher SBP, and HbA1c ≥10%. Among these, the strongest predictor was BMI with an odds ratio of 7.920.
Conclusion: This study highlights the association between hypothyroidism and IHD, particularly in patients with the identified risk factors. It emphasizes the importance of screening for thyroid function in IHD patients, especially those with the mentioned characteristics.
Antithyroid peroxidase; Cardiovascular disease; Hypothyroidism; Ischemic heart disease; Left ventricular ejection fraction & non-communicable diseases
Preview Article PDF
Rezwana I, Pathan M F, Amin F, Rahman M. A, Hasan M.M, Roy NC, Dutta M, Bhowmik GC, Roy H and Barua S. Risk factors of ischemic heart disease among hypothyroid patients in Bangladesh. World Journal of Biology Pharmacy and Health Sciences, 2025, 22(01), 356-371. Article DOI: https://doi.org/10.30574/wjbphs.2025.22.1.0336.